Erectile Dysfunction Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Erectile Dysfunction Drugs Market (Viagra, Cialis, Levitra/Staxyn, Stendra/Spedra, Zydena, MUSE, Mvix and Helleva) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Erectile</strong> <strong>Dysfunction</strong> <strong>Drugs</strong> <strong>Market</strong><br />
<strong>Forecast</strong>s state that by the end of <strong>2019</strong>, the erectile dysfunction drugs market is expected to<br />
witness a major decline in the world. Owing to weak pipeline development the erectile<br />
dysfunction drugs market will experience a low success rate in the matters of new drug<br />
formulations as well.<br />
Geographically, the North American market for erectile dysfunction drugs was valued at<br />
US$2,098.4 million in 2012 <strong>and</strong> is expected to continue to lead throughout the forecast period in<br />
terms of revenue generation.<br />
TABLE OF CONTENT<br />
Chapter 1 Preface<br />
1.1 Report Description<br />
1.2 <strong>Market</strong> Segmentation<br />
1.3 Research Methodology<br />
1.4 List of Abbreviations<br />
Chapter 2 Executive Summary<br />
Chapter 3 <strong>Market</strong> Overview<br />
3.1 Introduction to <strong>Erectile</strong> <strong>Dysfunction</strong><br />
3.2 Current <strong>Market</strong> <strong>Trends</strong> <strong>and</strong> Future Outlook<br />
3.2.1 Impact of Generics<br />
Transparency <strong>Market</strong> Research<br />
4